What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents?
- 29 February 1992
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 112 (2) , 171-181
- https://doi.org/10.1016/0041-008x(92)90185-u
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cell Proliferation in CarcinogenesisScience, 1990
- Development of a physiologically based pharmacokinetic model for chloroformToxicology and Applied Pharmacology, 1990
- Mutagenesis and carcinogenesis: Endogenous and exogenous factorsEnvironmental and Molecular Mutagenesis, 1989
- Comparative toxicity and safety profile of fenofibrate and other fibric acid derivativesThe American Journal of Medicine, 1987
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Changes in thyroidal function and liver UDPglucuronosyltransferase activity in rats following administration of a novel imidazole (SC-37211)Toxicology and Applied Pharmacology, 1985
- Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to manFood and Cosmetics Toxicology, 1981
- Epidemiological Studies of Medically Used DrugsPublished by Springer Nature ,1980
- Metabolism of Chloroform—I. The Metabolism of [14C] Chloroform by Different SpeciesXenobiotica, 1974
- Quantitative Analyse der KrebsentstehungZeitschrift für Naturforschung B, 1948